Stockreport

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

BioRestorative Therapies, Inc.  (BRTX) 
NASDAQ:AMEX Investor Relations: biorestorative.com/content/investor-relations
PDF – Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints – – Patient reported efficacy outcomes show a material decre [Read more]